With Sonic, PIQ was set to get royalty revenue of about $40 USD per test.
With the new strategy PIQ set to get revenue $400 USD per test, but with increased cost, maybe $100 per test.
Not to understate the importance of early diagnosis of endometriosis of Eso cancer, but the clinical roadshow is suggesting Promarker-D at least annually for diabetics!
With Sonic, PIQ was set to get royalty revenue of about $40 USD...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.015(3.90%) |
Mkt cap ! $60.50M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 39.5¢ | 37.0¢ | $457.2K | 1.200M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 49050 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 19500 | 1 |
View Market Depth
| Last trade - 15.39pm 13/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |